Skip to Main Content

INFORMATION FOR

David Banach

MD, MPH, MS
Lecturer in Epidemiology (Microbial Diseases)

Contact Information

David Banach, MD, MPH, MS

Mailing Address

  • Epidemiology of Microbial Diseases

    PO Box 208022

    New Haven, CT 06520-8022

    United States

Research Summary

My current research focuses on the epidemiology, prevention and outcomes of infections with multi-drug resistant bacterial pathogens. The organisms of focus include vancomycin-resistant enterococci (VRE) and multi-drug resistant gram-negative organisms, including those resistant to carbapenem antibiotics.

Specialized Terms; Healthcare-associated infections; Influenza vaccination; Infections in solid organ transplant recipients

Coauthors

Research Interests

Influenza Vaccines; Carbapenems; Infectious Disease Transmission, Professional-to-Patient; Drug Resistance, Multiple, Bacterial; Infectious Disease Medicine; Vancomycin-Resistant Enterococci; Transplant Recipients

Selected Publications

  • Decolonization Strategies for Infection Control of Gram-Negative BacilliTailor N, Thomas D, Banach D. Decolonization Strategies for Infection Control of Gram-Negative Bacilli 2022, 285-291. DOI: 10.1007/978-3-030-98427-4_24.
  • Isolation Precautions for Visitors to Healthcare SettingsCohen A, Simon M, Banach D. Isolation Precautions for Visitors to Healthcare Settings 2022, 21-30. DOI: 10.1007/978-3-030-98427-4_4.
  • 1167. Hospital Readmissions among Infants Diagnosed with Early-Onset Neonatal Sepsis in ConnecticutHudon R, Leung V, Leung V, Petit S, Banach D. 1167. Hospital Readmissions among Infants Diagnosed with Early-Onset Neonatal Sepsis in Connecticut Open Forum Infectious Diseases 2021, 8: 675-675. PMCID: PMC8644067, DOI: 10.1093/ofid/ofab466.1360.
  • Surveillance of Candidemia in Connecticut: An Epidemiological Comparison Between Two PeriodsGleason-Vergados J, Banach D, Clogher P, Meek J. Surveillance of Candidemia in Connecticut: An Epidemiological Comparison Between Two Periods Antimicrobial Stewardship & Healthcare Epidemiology 2021, 1: s79-s80. PMCID: PMC9551423, DOI: 10.1017/ash.2021.156.
  • 790. Evaluation of Connecticut Medical Providers Concordance with 2017 IDSA/SHEA Clostridioides difficile Treatment Guidelines in New Haven County, 2017-2019Luc C, Olson D, Banach D, Hadler J, Clogher P. 790. Evaluation of Connecticut Medical Providers Concordance with 2017 IDSA/SHEA Clostridioides difficile Treatment Guidelines in New Haven County, 2017-2019 Open Forum Infectious Diseases 2020, 7: s439-s439. PMCID: PMC7777245, DOI: 10.1093/ofid/ofaa439.980.
  • A Statewide Assessment of Antifungal Stewardship Activities in Acute-Care Hospitals in ConnecticutBromberg R, Leung V, Maloney M, Paranandi A, Banach D. A Statewide Assessment of Antifungal Stewardship Activities in Acute-Care Hospitals in Connecticut Infection Control And Hospital Epidemiology 2020, 41: s105-s105. DOI: 10.1017/ice.2020.609.
  • Epidemiology and Microbiology of Outpatient Cases of Carbapenem-Resistant Enterobacteriaceae in Connecticut During 2018Gupta S, Leung V, Maloney M, Macierowski B, Banach D. Epidemiology and Microbiology of Outpatient Cases of Carbapenem-Resistant Enterobacteriaceae in Connecticut During 2018 Infection Control And Hospital Epidemiology 2020, 41: s216-s216. DOI: 10.1017/ice.2020.759.
  • 1162. An Evaluation of Metrics for Catheter-Associated Urinary Tract Infections (CAUTIs): A Statewide ComparisonPepe D, Maloney M, Leung V, Harizaj A, Banach D, Dembry L, Dembry L, Advani S. 1162. An Evaluation of Metrics for Catheter-Associated Urinary Tract Infections (CAUTIs): A Statewide Comparison Open Forum Infectious Diseases 2019, 6: s415-s416. PMCID: PMC6809441, DOI: 10.1093/ofid/ofz360.1025.
  • 536. Challenges in Using MALDI-TOF Technology to Assess for KPC Resistance in Klebsiella pneumoniae isolates in AmericaThompson M, Banach D, Nishimura C, Muyombwe A. 536. Challenges in Using MALDI-TOF Technology to Assess for KPC Resistance in Klebsiella pneumoniae isolates in America Open Forum Infectious Diseases 2019, 6: s256-s257. PMCID: PMC6811151, DOI: 10.1093/ofid/ofz360.605.
  • OsteomyelitisAbrantes-Figueiredo J, Chowdhury J, Manu C, Banach D. Osteomyelitis 2019, 427-438. DOI: 10.1007/978-3-319-17918-6_34.
  • Medical Management of the Infected Diabetic FootWasser J, Edmonds M, Banach D. Medical Management of the Infected Diabetic Foot 2019, 505-516. DOI: 10.1007/978-3-319-17918-6_40.
  • Severe Babesiosis at DeliveryShah N, Sharma T, Manek G, Stettmeier K, Banach D, Datta D. Severe Babesiosis at Delivery 2019, a6626-a6626. DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a6626.
  • 2396. Fosfomycin Resistance Among Carbapenem-Resistant Enterobacteriaceae Clinical Isolates in Connecticut, 2017Snayd M, Leung V, Maloney M, Durante A, Macierowski B, Noel D, Muyombwe A, Razeq J, Banach D. 2396. Fosfomycin Resistance Among Carbapenem-Resistant Enterobacteriaceae Clinical Isolates in Connecticut, 2017 Open Forum Infectious Diseases 2018, 5: s714-s715. PMCID: PMC6253430, DOI: 10.1093/ofid/ofy210.2049.
  • 256. A Cross-Disciplinary Educational Approach: Antibiotic Prescribing Practices and the Use of Prophylactic Antibiotics Prior to Dental ProceduresMcCarthy M, Banach D, Andrews R. 256. A Cross-Disciplinary Educational Approach: Antibiotic Prescribing Practices and the Use of Prophylactic Antibiotics Prior to Dental Procedures Open Forum Infectious Diseases 2018, 5: s108-s108. PMCID: PMC6255480, DOI: 10.1093/ofid/ofy210.267.
  • 2411. Expanded Susceptibility and Resistance Mechanism Testing Among Carbapenem-Resistant Enterobacteriaceae in Connecticut, 2017Durante A, Maloney M, Leung V, Macierowski B, Noel D, Razeq J, Banach D. 2411. Expanded Susceptibility and Resistance Mechanism Testing Among Carbapenem-Resistant Enterobacteriaceae in Connecticut, 2017 Open Forum Infectious Diseases 2018, 5: s721-s721. PMCID: PMC6253689, DOI: 10.1093/ofid/ofy210.2064.
  • Exposure WorkupsBanach D, Babcock H, Dembry L. Exposure Workups 2018, 325-349. DOI: 10.1017/9781107153165.026.
  • The Epidemiology and Microbiology of Outpatient Carbapenem-Resistant EnterobacteriaceaeDurante, Maloney M, Banach D. The Epidemiology and Microbiology of Outpatient Carbapenem-Resistant Enterobacteriaceae Open Forum Infectious Diseases 2017, 4: s145-s145. DOI: 10.1093/ofid/ofx163.227.
  • Decolonization in Infection Control of Gram-Negative BacilliThomas D, Banach D. Decolonization in Infection Control of Gram-Negative Bacilli 2017, 235-242. DOI: 10.1007/978-3-319-60980-5_24.
  • Isolation Precautions for Visitors to Healthcare SettingsSfeir M, Simon M, Banach D. Isolation Precautions for Visitors to Healthcare Settings 2017, 19-27. PMCID: PMC7123668, DOI: 10.1007/978-3-319-60980-5_4.
  • Infection Prevention and Control Issues After Solid Organ TransplantationBanach D, Seville M, Kusne S. Infection Prevention and Control Issues After Solid Organ Transplantation 2016, 843-867. PMCID: PMC7123530, DOI: 10.1007/978-3-319-28797-3_46.
  • The Epidemiology of Clostridium difficile Infections Among Oncology PatientsChang Y, Dembry L, Banach D. The Epidemiology of Clostridium difficile Infections Among Oncology Patients Open Forum Infectious Diseases 2015, 2: 931. DOI: 10.1093/ofid/ofv133.647.
  • Predictive Value of Rothman Index in Patients That Develop Febrile NeutropeniaRubio L, Lee A, Banach D. Predictive Value of Rothman Index in Patients That Develop Febrile Neutropenia Open Forum Infectious Diseases 2015, 2: 1224. DOI: 10.1093/ofid/ofv133.936.
  • Cervicofacial necrotizing fasciitis caused by Haemophilus influenzae serotype e in a patient with Sjogren's syndrome, systemic lupus erythematosus and hypocomplementaemiaAzar M, Folk D, Henderson T, Mehra S, Vining E, Banach D. Cervicofacial necrotizing fasciitis caused by Haemophilus influenzae serotype e in a patient with Sjogren's syndrome, systemic lupus erythematosus and hypocomplementaemia JMM Case Reports 2015, 2 DOI: 10.1099/jmmcr.0.000040.
  • Focal renal infections and papillary necrosisBanach D, Dembry L. Focal renal infections and papillary necrosis 2015, 434-438. DOI: 10.1017/cbo9781139855952.076.
  • Clinical and Molecular Epidemiology of Pretransplant Vancomycin-Resistant Enterococci (VRE) Colonization Among Patients Who Undergo Liver Transplantation.Banach D, Peaper D, Emre S, Fortune B, Dembry L. Clinical and Molecular Epidemiology of Pretransplant Vancomycin-Resistant Enterococci (VRE) Colonization Among Patients Who Undergo Liver Transplantation. Transplantation 2014, 98: 769. DOI: 10.1097/00007890-201407151-02627.